Justyna Leja

465 total citations
10 papers, 357 citations indexed

About

Justyna Leja is a scholar working on Genetics, Molecular Biology and Neurology. According to data from OpenAlex, Justyna Leja has authored 10 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Molecular Biology and 5 papers in Neurology. Recurrent topics in Justyna Leja's work include Virus-based gene therapy research (7 papers), Neuroblastoma Research and Treatments (5 papers) and RNA Interference and Gene Delivery (3 papers). Justyna Leja is often cited by papers focused on Virus-based gene therapy research (7 papers), Neuroblastoma Research and Treatments (5 papers) and RNA Interference and Gene Delivery (3 papers). Justyna Leja collaborates with scholars based in Sweden, United States and Finland. Justyna Leja's co-authors include Magnus Essand, Kjell Öberg, Valeria Giandomenico, Di Yu, Mohanraj Ramachandran, Berith Nilsson, Kenneth Wester, Thomas H. Tötterman, George Vasmatzis and Ricardo V. Lloyd and has published in prestigious journals such as PLoS ONE, Journal of Virology and Clinical Cancer Research.

In The Last Decade

Justyna Leja

10 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Justyna Leja Sweden 8 153 152 116 86 67 10 357
Riccardo Mesturini Italy 15 67 0.4× 120 0.8× 47 0.4× 48 0.6× 43 0.6× 18 481
Jennifer Ferris United States 6 134 0.9× 262 1.7× 90 0.8× 46 0.5× 5 0.1× 8 425
David Saceda‐Corralo Spain 17 33 0.2× 111 0.7× 104 0.9× 137 1.6× 9 0.1× 90 905
Francisco Lopez Spain 11 124 0.8× 80 0.5× 60 0.5× 93 1.1× 146 2.2× 19 389
Г. В. Селедцова Russia 12 137 0.9× 92 0.6× 23 0.2× 29 0.3× 20 0.3× 51 433
Sergio Zaccaria Scalinci Italy 13 26 0.2× 152 1.0× 19 0.2× 46 0.5× 51 0.8× 31 502
Lauren C. Strazzulla United States 10 118 0.8× 103 0.7× 30 0.3× 72 0.8× 7 0.1× 15 774
Jamie K. Hu United States 8 50 0.3× 129 0.8× 19 0.2× 45 0.5× 33 0.5× 17 298
Marlinde L. van den Boogaard Netherlands 11 37 0.2× 290 1.9× 58 0.5× 16 0.2× 52 0.8× 17 392
Judith Arnolds Germany 9 88 0.6× 76 0.5× 10 0.1× 30 0.3× 28 0.4× 15 312

Countries citing papers authored by Justyna Leja

Since Specialization
Citations

This map shows the geographic impact of Justyna Leja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justyna Leja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justyna Leja more than expected).

Fields of papers citing papers by Justyna Leja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justyna Leja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justyna Leja. The network helps show where Justyna Leja may publish in the future.

Co-authorship network of co-authors of Justyna Leja

This figure shows the co-authorship network connecting the top 25 collaborators of Justyna Leja. A scholar is included among the top collaborators of Justyna Leja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justyna Leja. Justyna Leja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ramachandran, Mohanraj, et al.. (2014). Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice. BMC Cancer. 14(1). 30–30. 51 indexed citations
2.
Jin, Chuan, et al.. (2013). Tat-PTD-Modified Oncolytic Adenovirus Driven by the SCG3 Promoter and ASH1 Enhancer for Neuroblastoma Therapy. Human Gene Therapy. 24(8). 766–775. 8 indexed citations
3.
Leja, Justyna, Di Yu, Bo Nilsson, et al.. (2011). Oncolytic adenovirus modified with somatostatin motifs for selective infection of neuroendocrine tumor cells. Gene Therapy. 18(11). 1052–1062. 27 indexed citations
4.
Essand, Magnus, Justyna Leja, Valeria Giandomenico, & Kjell Öberg. (2011). Oncolytic Viruses for the Treatment of Neuroendocrine Tumors. Hormone and Metabolic Research. 43(12). 877–883. 5 indexed citations
5.
Yu, Di, Chuan Jin, Justyna Leja, et al.. (2011). Adenovirus with Hexon Tat-Protein Transduction Domain Modification Exhibits Increased Therapeutic Effect in Experimental Neuroblastoma and Neuroendocrine Tumors. Journal of Virology. 85(24). 13114–13123. 32 indexed citations
6.
Jaźwa, Agnieszka, Paulina Kucharzewska, Justyna Leja, et al.. (2010). Combined vascular endothelial growth factor-A and fibroblast growth factor 4 gene transfer improves wound healing in diabetic mice. PubMed. 8(1). 6–6. 51 indexed citations
7.
Leja, Justyna, Berith Nilsson, Di Yu, et al.. (2010). Double-Detargeted Oncolytic Adenovirus Shows Replication Arrest in Liver Cells and Retains Neuroendocrine Cell Killing Ability. PLoS ONE. 5(1). e8916–e8916. 42 indexed citations
8.
Leja, Justyna, Ahmed Essaghir, Magnus Essand, et al.. (2008). Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas. Modern Pathology. 22(2). 261–272. 108 indexed citations
9.
Zagórska, Anna, Justyna Leja, Agnieszka Jaźwa, et al.. (2007). Construction of plasmid bicistronic vectors and their application for in vitro transfection. Biotechnologia. 66–81. 1 indexed citations
10.
Leja, Justyna, et al.. (2007). A Novel Chromogranin-A Promoter-Driven Oncolytic Adenovirus for Midgut Carcinoid Therapy. Clinical Cancer Research. 13(8). 2455–2462. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026